Follow-up after curative cancer surgery: Understanding costs and benefits

Annals of Surgical Oncology

Volumn 21, Issue 3, 2014, Pages 731-732

  Fahy, Bridget N ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; METASTASIS; NON PROFIT ORGANIZATION; PRIMARY TUMOR; SECOND CANCER;

COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HUMANS; NEOPLASMS;

EID: 84896695194     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3368-9     Document Type: Editorial

References (5)

1. American Cancer Society. Cancer treatment and survivorship facts and figures 2012-2013. 2012. Available from: http://www.cancer.org/acs/groups/ content/@epidemiologysurveilance/documents/document/acspc-033876.pdf. Accessed 20 Oct 2013.
2. Institute of Medicine. Educating cancer health providers. 2005. Available from: http://www.iom.edu/~/media/Files/Report%20Files/2005/From-Cancer-Patient- to-Cancer-Survivor-Lost-in-Transition/factsheeteducation.pdf. Accessed 20 Oct 2013.
3. Smyth JF. The problem of monitoring remission. The ASCO Post. 2012;3(13):1.
4. Brennan MF. Follow-up is valuable and effective: true, true and unrelated? Ann Surg Oncol. 2000;7:2-3.
5. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117-128.